Literature DB >> 19805167

Malignant cell-derived PlGF promotes normalization and remodeling of the tumor vasculature.

Eva-Maria Hedlund1, Kayoko Hosaka, Zhaodong Zhong, Renhai Cao, Yihai Cao.   

Abstract

Vascular functions of PlGF remain poorly understood and controversial. Here, we show that tumor cell-derived PlGF-1 and PlGF-2 displayed significant remodeling effects on the tumor vasculature, leading to a normalized vascular phenotype and improved functions against leakage. In two murine tumor models, that is, T241 fibrosarcoma and Lewis lung carcinoma, stable expression of PlGF-1 and PlGF-2 in tumor cells resulted in significant reduction of tumor microvascular density and branch formation. Markedly, the vasculature in PlGF-expressing tumors consisted of relatively large-diameter microvessels with substantial improvement of pericyte coverage. Similarly, PlGF-induced vascular normalization and remodeling were also observed in a spontaneous human choriocarcinoma that expressed endogenous PlGF. Our findings shed light on functions of PlGF as a vascular remodeling factor that normalizes the tumor vasculature and thus may have conceptual implications of cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19805167      PMCID: PMC2752403          DOI: 10.1073/pnas.0908026106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  58 in total

1.  Novel VEGF family members: VEGF-B, VEGF-C and VEGF-D.

Authors:  X Li; U Eriksson
Journal:  Int J Biochem Cell Biol       Date:  2001-04       Impact factor: 5.085

Review 2.  VPF/VEGF and the angiogenic response.

Authors:  H F Dvorak
Journal:  Semin Perinatol       Date:  2000-02       Impact factor: 3.300

3.  Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions.

Authors:  P Carmeliet; L Moons; A Luttun; V Vincenti; V Compernolle; M De Mol; Y Wu; F Bono; L Devy; H Beck; D Scholz; T Acker; T DiPalma; M Dewerchin; A Noel; I Stalmans; A Barra; S Blacher; T VandenDriessche; A Ponten; U Eriksson; K H Plate; J M Foidart; W Schaper; D S Charnock-Jones; D J Hicklin; J M Herbert; D Collen; M G Persico
Journal:  Nat Med       Date:  2001-05       Impact factor: 53.440

4.  Pulmonary vascular resistance distribution and recruitment of microvascular surface area.

Authors:  K A Overholser; N A Lomangino; R E Parker; N A Pou; T R Harris
Journal:  J Appl Physiol (1985)       Date:  1994-08

5.  Vascular endothelial growth factor-B-deficient mice display an atrial conduction defect.

Authors:  K Aase; G von Euler; X Li; A Pontén; P Thorén; R Cao; Y Cao; B Olofsson; S Gebre-Medhin; M Pekny; K Alitalo; C Betsholtz; U Eriksson
Journal:  Circulation       Date:  2001-07-17       Impact factor: 29.690

6.  Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium.

Authors:  G H Fong; J Rossant; M Gertsenstein; M L Breitman
Journal:  Nature       Date:  1995-07-06       Impact factor: 49.962

7.  Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1(+) stem cells from bone-marrow microenvironment.

Authors:  Koichi Hattori; Beate Heissig; Yan Wu; Sergio Dias; Rafael Tejada; Barbara Ferris; Daniel J Hicklin; Zhenping Zhu; Peter Bohlen; Larry Witte; Jan Hendrikx; Neil R Hackett; Ronald G Crystal; Malcolm A S Moore; Zena Werb; David Lyden; Shahin Rafii
Journal:  Nat Med       Date:  2002-07-01       Impact factor: 53.440

8.  Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1.

Authors:  Aernout Luttun; Marc Tjwa; Lieve Moons; Yan Wu; Anne Angelillo-Scherrer; Fang Liao; Janice A Nagy; Andrea Hooper; Josef Priller; Bert De Klerck; Veerle Compernolle; Evis Daci; Peter Bohlen; Mieke Dewerchin; Jean-Marc Herbert; Roy Fava; Patrick Matthys; Geert Carmeliet; Désiré Collen; Harold F Dvorak; Daniel J Hicklin; Peter Carmeliet
Journal:  Nat Med       Date:  2002-07-01       Impact factor: 53.440

Review 9.  VEGF and the quest for tumour angiogenesis factors.

Authors:  Napoleone Ferrara
Journal:  Nat Rev Cancer       Date:  2002-10       Impact factor: 60.716

10.  Placenta growth factor-1 antagonizes VEGF-induced angiogenesis and tumor growth by the formation of functionally inactive PlGF-1/VEGF heterodimers.

Authors:  Anna Eriksson; Renhai Cao; Robert Pawliuk; Sanna Maria Berg; Monica Tsang; Danielle Zhou; Christina Fleet; Katerina Tritsaris; Steen Dissing; Philippe Leboulch; Yihai Cao
Journal:  Cancer Cell       Date:  2002-02       Impact factor: 31.743

View more
  25 in total

1.  Distal-less 3 haploinsufficiency results in elevated placental oxidative stress and altered fetal growth kinetics in the mouse.

Authors:  P A Clark; J L Brown; S Li; A K Woods; L Han; J L Sones; R L Preston; T L Southard; R L Davisson; M S Roberson
Journal:  Placenta       Date:  2012-07-19       Impact factor: 3.481

2.  Adipose angiogenesis: quantitative methods to study microvessel growth, regression and remodeling in vivo.

Authors:  Yuan Xue; Sharon Lim; Ebba Bråkenhielm; Yihai Cao
Journal:  Nat Protoc       Date:  2010-04-22       Impact factor: 13.491

Review 3.  Off-tumor target--beneficial site for antiangiogenic cancer therapy?

Authors:  Yihai Cao
Journal:  Nat Rev Clin Oncol       Date:  2010-08-03       Impact factor: 66.675

4.  Antiangiogenic agents significantly improve survival in tumor-bearing mice by increasing tolerance to chemotherapy-induced toxicity.

Authors:  Danfang Zhang; Eva-Maria E Hedlund; Sharon Lim; Fang Chen; Yin Zhang; Baocun Sun; Yihai Cao
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-18       Impact factor: 11.205

Review 5.  Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases.

Authors:  Peter Carmeliet; Rakesh K Jain
Journal:  Nat Rev Drug Discov       Date:  2011-06       Impact factor: 84.694

Review 6.  PlGF: a multitasking cytokine with disease-restricted activity.

Authors:  Mieke Dewerchin; Peter Carmeliet
Journal:  Cold Spring Harb Perspect Med       Date:  2012-08-01       Impact factor: 6.915

7.  Sarcoma Tumor Microenvironment.

Authors:  Panagiotis Tsagozis; Jordi Gonzalez-Molina; Anna-Maria Georgoudaki; Kaisa Lehti; Joseph Carlson; Andreas Lundqvist; Felix Haglund; Monika Ehnman
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

Review 8.  Resistance and escape from antiangiogenesis therapy: clinical implications and future strategies.

Authors:  Justin N Bottsford-Miller; Robert L Coleman; Anil K Sood
Journal:  J Clin Oncol       Date:  2012-09-24       Impact factor: 44.544

9.  Vascular endothelial growth factor-dependent spatiotemporal dual roles of placental growth factor in modulation of angiogenesis and tumor growth.

Authors:  Xiaojuan Yang; Yin Zhang; Yunlong Yang; Sharon Lim; Ziquan Cao; Janusz Rak; Yihai Cao
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-05       Impact factor: 11.205

10.  The antitumor efficacy of monomeric disintegrin obtustatin in S-180 sarcoma mouse model.

Authors:  Narine Ghazaryan; Naira Movsisyan; Joana Catarina Macedo; Sara Vaz; Naira Ayvazyan; Luis Pardo; Elsa Logarinho
Journal:  Invest New Drugs       Date:  2019-01-25       Impact factor: 3.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.